Unknown Author
January 22, 2026
Kirkland Advises Montagu on Acquisition of Johnson Matthey’s Medical Device Components Business

1 min
AI-made summary
- Kirkland & Ellis is advising private equity firm Montagu on its proposed acquisition of Johnson Matthey Plc’s medical device components (MDC) business, as announced on March 20, 2024
- MDC specializes in developing and manufacturing miniature, high-precision components for minimally invasive medical devices, using Platinum Group Metals and Nitinol
- Following the acquisition, MDC will operate as a standalone company
- The Kirkland team includes partners and associates from corporate, debt finance, technology, IP, and tax practices.
Kirkland & Ellis is advising private equity firm Montagu on the proposed acquisition of Johnson Matthey Plc’s medical device components (MDC) business. The definitive agreement was announced on March 20, 2024. MDC develops and manufactures miniature components for minimally invasive medical devices used in high-growth clinical specialties. The business focuses on complex and high-precision components made from Platinum Group Metals and Nitinol. MDC will operate as a standalone company. Read the transaction press release The Kirkland team is being led by corporate partners Shayla Harlev, Aprajita Dhundia, Adrian Maguire and Duncan Enista and associates Carmella Crinnion, Matt Suhosky and Bing Yi Lim; debt finance partners Ashley Gregory and Brittany Roger; technology & IP transactions partners Seth Traxler, Kevin Jacobsen and Joanna Schlingbaum; and tax partners Mark Schwed, Peter Abbott and William Dong and associates Nicole Martin and Michael Akpomiemie.
Article Author
Unknown Author
The Sponsor
